Biopharmas raising money in public or private financings, including: Appili, Baudax, Celularity, Laekna, Locus, Tenax.

An unknown U.K. biotech, RQ Biotechnology Ltd., has emerged from stealth mode with a $157 million licensing deal with Astrazeneca plc for its monoclonal antibodies, aimed at protecting vulnerable and immunosuppressed people against SARS-CoV-2.

Med-tech firms raising money in public or private financings, including: Mirvie, Vivasure Medical.

Kriya Therapeutics Inc. has raised a $270 million series C financing to further develop its pipeline of gene therapies for treating cancer, ophthalmological problems, and rare and chronic diseases. The Redwood City, Calif.-based company has greatly expanded its employee roster, from about seven people to around 160 people, since its $80 million series A in May 2020 and scaled its learning-enabled tech and cloud computing abilities. It also further solidified its technology, manufacturing, R&D, and therapeutics units, something it plans to continue with the series C money.

Med-tech firms raising money in public or private financings, including: Greenbrook, Predictive Oncology, Success TMS.

Biopharmas raising money in public or private financings, including: Biofrontera, Inventiva, Kriya, Zentalis.

Med-tech firms raising money in public or private financings, including: Medx.

Biopharmas raising money in public or private financings, including: Belite, Vallon.